Drug Delivery Systems

Researchers investigate novel methods to deliver therapeutic agents to specific sites within the body, aiming to improve treatment efficacy and reduce side effects. This work encompasses the design and synthesis of advanced materials, including nanoparticles, polymers, and hydrogels, for controlled and targeted release of drugs. Studies explore various administration routes and mechanisms, such as oral, injectable, and transdermal delivery, as well as stimuli-responsive systems that release drugs in response to internal or external cues. Key areas of focus include developing systems for chronic disease management, infectious disease treatment, and cancer therapy.

This research holds particular relevance for Arkansas by addressing critical public health needs and supporting economic development. Efforts to improve drug delivery for conditions like diabetes, cardiovascular disease, and cancer can lead to better health outcomes for the state's population. Furthermore, advancements in biomaterials and nanotechnology for drug delivery can foster innovation within the state's growing biotechnology and pharmaceutical sectors, potentially creating new jobs and economic opportunities. The development of efficient delivery systems for agricultural chemicals also aligns with Arkansas's significant agricultural industry.

This field draws upon expertise from diverse disciplines, including chemistry, materials science, engineering, biology, and pharmacology. The research benefits from extensive collaboration among faculty at multiple Arkansas institutions, including the University of Arkansas at Fayetteville, the University of Arkansas for Medical Sciences, the University of Arkansas at Little Rock, and the National Center for Toxicological Research. These collaborations facilitate a comprehensive approach to understanding and overcoming the challenges in modern drug delivery.